Reversible and irreversible tumor progression of a weakly malignant rat mammary carcinoma cell line by in vitro exposure to epidermal growth factor

Int J Oncol. 1998 Jan;12(1):197-202. doi: 10.3892/ijo.12.1.197.

Abstract

We examined the effects of epidermal growth factor (EGF) on tumor progression of a weakly malignant rat mammary carcinoma cell line, ER-1. In vitro treatment with EGF enhanced tumorigenicity, metastatic capacity and in vitro invasive capacity of ER-1 cells. The increased malignancy of ER-1 cells was reversible, when the cells were pretreated with EGF for 24 h, whereas it was irreversible when pretreated with EGF for 1 month. EGF treatment elevated the intracellular peroxide level in ER-1 cells. When ER-1 cells were treated with EGF in the presence of N-acetylcysteine, a chemical antioxidant, the reversible or irreversible EGF-induced progression was inhibited. These results suggest that the reversible or irreversible tumor progression in ER-1 cells occur in accordance with the duration of exposure to EGF, and that reactive oxygen species may be involved in the progression.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylcysteine / pharmacology
  • Adenocarcinoma / pathology*
  • Animals
  • DNA Damage / drug effects
  • DNA Primers / chemistry
  • Disease Progression
  • Epidermal Growth Factor / pharmacology*
  • ErbB Receptors / genetics
  • ErbB Receptors / metabolism
  • Female
  • Flow Cytometry
  • Free Radical Scavengers / pharmacology
  • In Vitro Techniques
  • Mammary Neoplasms, Experimental / pathology*
  • Microscopy, Confocal
  • Neoplasm Invasiveness
  • Oxidative Stress / drug effects
  • Peroxides / metabolism
  • Rats
  • Rats, Inbred SHR
  • Reverse Transcriptase Polymerase Chain Reaction
  • Tumor Cells, Cultured / drug effects

Substances

  • DNA Primers
  • Free Radical Scavengers
  • Peroxides
  • Epidermal Growth Factor
  • ErbB Receptors
  • Acetylcysteine